33.60
-0.34 (-1.00%)
| Penutupan Terdahulu | 33.94 |
| Buka | 33.37 |
| Jumlah Dagangan | 24,939 |
| Purata Dagangan (3B) | 23,088 |
| Modal Pasaran | 293,702,976 |
| Harga / Jualan (P/S) | 2.97 |
| Harga / Buku (P/B) | 6.86 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 25 Mar 2025 |
| Margin Keuntungan | -11.15% |
| Margin Operasi (TTM) | -5.14% |
| EPS Cair (TTM) | -1.14 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 48.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 82.97% |
| Nisbah Semasa (MRQ) | 2.18 |
| Aliran Tunai Operasi (OCF TTM) | -1.80 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 1.77 M |
| Pulangan Atas Aset (ROA TTM) | -4.50% |
| Pulangan Atas Ekuiti (ROE TTM) | -23.74% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Menurun | Bercampur |
| Medical Instruments & Supplies (Global) | Menurun | Menurun | |
| Stok | Sanara MedTech Inc. | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 5.0 |
| Aktiviti Orang Dalam | 1.5 |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | -1.0 |
| Osilator Teknikal | -0.5 |
| Purata | 1.40 |
|
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 65.57% |
| % Dimiliki oleh Institusi | 10.89% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| World Investment Advisors, Llc | 30 Sep 2024 | 21,112 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 53.00 (HC Wainwright & Co., 57.74%) | Beli |
| Median | 49.50 (47.32%) | |
| Rendah | 46.00 (Cantor Fitzgerald, 36.91%) | Beli |
| Purata | 49.50 (47.32%) | |
| Jumlah | 2 Beli | |
| Harga Purata @ Panggilan | 30.26 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 15 May 2025 | 53.00 (57.74%) | Beli | 30.88 |
| 26 Mar 2025 | 51.00 (51.79%) | Beli | 29.63 | |
| Cantor Fitzgerald | 26 Mar 2025 | 46.00 (36.90%) | Beli | 29.63 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| DESUTTER ROBERT ANDREW | 30.99 | - | 3,746 | 116,089 |
| MACK ROSZELL III | 30.99 | - | 3,433 | 106,389 |
| MAJOR ERIC D | 30.99 | - | 3,277 | 101,554 |
| MYERS KEITH G | 30.99 | - | 2,965 | 91,885 |
| ORTWEIN SARA N | 30.99 | - | 3,277 | 101,554 |
| SALAMONE ANN BEAL | 30.99 | - | 2,809 | 87,051 |
| TANZBERGER ERIC D | 30.99 | - | 3,590 | 111,254 |
| Jumlah Keseluruhan Kuantiti Bersih | 23,097 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | 715,776 | |||
| Purata Pembelian Keseluruhan ($) | 30.99 | |||
| Purata Jualan Keseluruhan ($) | - | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| MACK ROSZELL III | Pengarah | 22 May 2025 | Diperolehi (+) | 3,433 | 30.99 | 106,389 |
| DESUTTER ROBERT ANDREW | Pengarah | 22 May 2025 | Diperolehi (+) | 3,746 | 30.99 | 116,089 |
| MAJOR ERIC D | Pengarah | 22 May 2025 | Diperolehi (+) | 3,277 | 30.99 | 101,554 |
| MYERS KEITH G | Pengarah | 22 May 2025 | Diperolehi (+) | 2,965 | 30.99 | 91,885 |
| ORTWEIN SARA N | Pengarah | 22 May 2025 | Diperolehi (+) | 3,277 | 30.99 | 101,554 |
| SALAMONE ANN BEAL | Pengarah | 22 May 2025 | Diperolehi (+) | 2,809 | 30.99 | 87,051 |
| TANZBERGER ERIC D | Pengarah | 22 May 2025 | Diperolehi (+) | 3,590 | 30.99 | 111,254 |
| Tarikh | Jenis | Butiran |
|---|---|---|
| 14 May 2025 | Pengumuman | Sanara MedTech Inc. Reports First Quarter 2025 Financial Results (Unaudited) |
| 23 Apr 2025 | Pengumuman | Sanara MedTech to Report First Quarter 2025 Financial Results on May 14, 2025 |
| 10 Apr 2025 | Pengumuman | Sanara MedTech to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025 |
| 25 Mar 2025 | Pengumuman | Sanara MedTech Inc. Reports Fourth Quarter and Full Year 2024 Financial Results (Unaudited) |
| 11 Mar 2025 | Pengumuman | Sanara MedTech to Report Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |